Pegavision Corp. (6491.TW)
Taoyuan City, TPE, TW
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Kinsus Interconnect Technology Corp.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.42% | +5.33% | +2.77% | +0.68% | -10.29% | +4.04% | -16.71% | -14.80% | -30.15% | +290.08% | +87.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%+3.3% Q1'26: +18.3% (vs Q1'25)
-
EPS growth Hardware, Equipment & Parts: +20.2%-11.6% Q1'26: -3.5% (vs Q1'25)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%+23.0% Q1'26: -1.1% (vs Q1'25)
-
EBIT margin Hardware, Equipment & Parts: +8.7%+29.4% ★ Q1'26: +28.8% (vs Q1'25)
-
ROIC Hardware, Equipment & Parts: +5.7%+20.0% ★ Q1'26: +22.5% (vs Q1'25)
-
Share dilution Hardware, Equipment & Parts: +0.0%+0.3% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×0.44× ★ Q1'26: 0.46× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.36B
est: 3.25B (+3.1%)
|
3.98B
est: 3.98B (+0.0%)
|
5.60B
est: 5.61B (-0.2%)
|
6.32B
est: 6.32B (+0.0%)
|
6.79B
est: 7.08B (-4.1%)
|
6.82B
est: 6.81B (+0.0%)
|
7.04B
est: 7.12B (-1.1%)
|
7.83B
7.63B – 8.09B
+10.0% YoY
|
8.54B
8.53B – 8.55B
+9.1% YoY
|
| EBITDA |
1.27B
est: 1.33B (-4.8%)
|
1.46B
est: 1.63B (-10.3%)
|
2.11B
est: 2.30B (-7.9%)
|
2.77B
est: 2.59B (+6.9%)
|
2.96B
est: 3.01B (-1.6%)
|
2.92B
est: 2.90B (+0.8%)
|
2.85B
est: 3.03B (-5.9%)
|
3.33B
3.24B – 3.44B
+10.0% YoY
|
3.63B
3.63B – 3.64B
+9.1% YoY
|
| EBIT |
583.01M
est: 901.02M (-35.3%)
|
848.81M
est: 1.10B (-22.9%)
|
1.45B
est: 1.55B (-6.7%)
|
1.84B
est: 1.75B (+5.1%)
|
2.02B
est: 2.42B (-16.4%)
|
2.19B
est: 2.33B (-5.9%)
|
2.07B
est: 2.43B (-14.9%)
|
2.68B
2.61B – 2.76B
+10.0% YoY
|
2.92B
2.92B – 2.92B
+9.1% YoY
|
| Net Income |
475.49M
est: 487.51M (-2.5%)
|
715.36M
est: 805.70M (-11.2%)
|
1.25B
est: 1.36B (-7.9%)
|
1.54B
est: 1.72B (-10.2%)
|
1.66B
est: 2.00B (-17.3%)
|
1.83B
est: 1.89B (-3.0%)
|
1.63B
est: 1.67B (-2.5%)
|
1.84B
1.71B – 1.99B
+10.4% YoY
|
2.05B
2.02B – 2.08B
+11.1% YoY
|
| SGA |
622.81M
est: 541.03M (+15.1%)
|
770.82M
est: 661.45M (+16.5%)
|
948.61M
est: 932.30M (+1.7%)
|
926.50M
est: 1.05B (-11.8%)
|
1.05B
est: 1.13B (-6.4%)
|
1.13B
est: 1.08B (+4.4%)
|
1.12B
est: 1.13B (-1.6%)
|
1.25B
1.21B – 1.29B
+10.0% YoY
|
1.36B
1.36B – 1.36B
+9.1% YoY
|
| EPS |
7.52
est: 6.19 (+21.5%)
|
10.09
est: 10.23 (-1.4%)
|
17.61
est: 17.22 (+2.3%)
|
21.75
est: 21.80 (-0.3%)
|
22.83
est: 25.29 (-9.7%)
|
23.46
est: 23.84 (-1.6%)
|
20.87
est: 21.10 (-1.1%)
|
23.37
21.71 – 25.14
+10.7% YoY
|
25.94
25.56 – 26.33
+11.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Dividend ETF EDIV | 0.58% | 7.10M | 0.49% |
| 2 | iShares Ageing Population UCITS ETF AGED.L | 0.04% | 377.5K | 0.40% |
| 3 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 281.5K | 0.65% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 47.1K | 0.42% |
| 5 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.04% | 28.3K | 0.74% |
| 6 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.03% | 103.1K | 0.74% |
| 7 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.03% | 11.0K | 0.54% |
| 8 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 104.7K | 0.55% |
| 9 | Avantis Emerging Markets Value ETF AVES | 0.02% | 235.4K | 0.36% |
| 10 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 47.1K | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming-Dong Kuo | Chairman of the Board & Chief Strategy Officer | — | male |
| Te-Sheng Yang | President & Representative Director | — | male |
| Terry Chang | Vice President | — | male |
| Tony Wang | Senior Director of Finance & Accounting Division and Corporate Governance Officer | — | male |
| Yi-Hong Pan | Deputy General Manager | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6491.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
